Dementia Index Shows Validity for Predicting Age of Onset of MCI, Alzheimer Disease
By Elana Gotkine HealthDay Reporter
MONDAY, Jan. 13, 2025 -- The Florey Dementia Index (FDI) is valid for predicting the age of onset of mild cognitive impairment (MCI) and Alzheimer disease (AD), according to a study published online Jan. 8 in JAMA Network Open.
Chenyin Chu, from The Florey Institute of Neuroscience and Mental Health in Parkville, Australia, and colleagues examined whether age at onset of MCI and AD can be predicted in a prognostic study using data from two aging and dementia cohort studies for model development and validation of the FDI: the Australian Imaging, Biomarker and Lifestyle (AIBL) study and the Alzheimer's Disease Neuroimaging Initiative (ADNI). Data were included for 1,665 AIBL participants, 2,029 ADNI participants, and 93 participants from the Anti-Amyloid Treatment in Asymptomatic Alzheimer (A4) study.
The researchers found that the FDI achieved mean absolute errors of 2.78 and 1.48 years for predicting MCI onset and AD onset, respectively. In the simulated trial with A4 participants, the FDI achieved mean absolute errors of 1.57 and 0.70 years for predicting MCI onset and AD onset, respectively.
"The promising results achieved in the present study support the potential clinical use of the FDI model so that timely diagnostics, treatment, and care plans for individuals at risk can be arranged," the authors write.
The Alzheimer's Disease Neuroimaging Initiative is funded by contributions from biopharmaceutical companies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Parent-Reported Firearm Storage Poor Estimator of Teen Perceived Access
MONDAY, June 16, 2025 -- Parent-reported firearm storage seems to be a poor estimator of teen perceived firearm access, according to a study published online June 10 in JAMA...
CT Colonography Cost-Effective, Clinically Effective for CRC Screening
MONDAY, June 16, 2025 -- Computed tomography colonography (CTC) is cost-effective and clinically effective for colorectal cancer (CRC) screening, according to a study published...
Global Incidence Rate of Rheumatoid Arthritis Increased From 1990 to 2021
MONDAY, June 16, 2025 -- The incidence rate of rheumatoid arthritis (RA) increased globally from 1990 to 2021, with the heaviest burden born by regions with a high...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.